tiprankstipranks
Advertisement
Advertisement

PLX Stock Latest News

Protalix Biotherapeutics Earnings Call Signals Strong Momentum
Company AnnouncementsProtalix Biotherapeutics Earnings Call Signals Strong Momentum
1d ago
PLX
PLX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
PLX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
15d ago
PLX
Protalix Shareholders Approve Directors, Compensation and Incentive Plan
PremiumCompany Announcements
Protalix Shareholders Approve Directors, Compensation and Incentive Plan
2M ago
8K
PLX
Ram Selvaraju Reiterates Buy on Protalix, Maintains $12 Price Target on Elfabrio Momentum and Pipeline Upside
PremiumRatings
Ram Selvaraju Reiterates Buy on Protalix, Maintains $12 Price Target on Elfabrio Momentum and Pipeline Upside
3M ago
PLX
Protalix Highlights Elfabrio Dosing Approvals and Growth Plans
PremiumCompany Announcements
Protalix Highlights Elfabrio Dosing Approvals and Growth Plans
3M ago
8K
PLX
Protalix Q1 Call: Milestone-Fueled Profit, Bold Targets
PremiumCompany AnnouncementsProtalix Q1 Call: Milestone-Fueled Profit, Bold Targets
3M ago
PLX
PLX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
PLX Upcoming Earnings Report: What to Expect?
4M ago
PLX
Protalix Earnings Call: EU Win, Cash Boost, Trade-Offs
Premium
Company Announcements
Protalix Earnings Call: EU Win, Cash Boost, Trade-Offs
5M ago
PLX
Protalix: EU Approval and Commercial Tailwinds for Elfabrio Underscore Undervalued Upside
PremiumRatings
Protalix: EU Approval and Commercial Tailwinds for Elfabrio Underscore Undervalued Upside
5M ago
PLX
PLX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
PLX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
PLX
Protalix Gains EU Approval for Extended Elfabrio Dosing
PremiumCompany Announcements
Protalix Gains EU Approval for Extended Elfabrio Dosing
6M ago
8K
PLX
Protalix, Chiesi Global Rare Diseases: EC approves dosing regimen for Elfabrio
PremiumThe Fly
Protalix, Chiesi Global Rare Diseases: EC approves dosing regimen for Elfabrio
6M ago
PLX
Protalix Advances RELEASE Gout Trial, Sharpening Its Long Term Biotech Upside
PremiumCompany AnnouncementsProtalix Advances RELEASE Gout Trial, Sharpening Its Long Term Biotech Upside
6M ago
PLX
Protalix Highlights Positive EMA Opinion on Elfabrio Dosing
Premium
Company Announcements
Protalix Highlights Positive EMA Opinion on Elfabrio Dosing
6M ago
8K
PLX
Protalix Wins EMA Panel Backing for New Elfabrio Dosing
Premium
Company Announcements
Protalix Wins EMA Panel Backing for New Elfabrio Dosing
7M ago
8K
PLX
Protalix, Chiesi Global: CHMP issues positive opinion for Elfabrio dosing
PremiumThe Fly
Protalix, Chiesi Global: CHMP issues positive opinion for Elfabrio dosing
7M ago
PLX
Protalix outlines 2026 rare-disease growth and pipeline strategy
PremiumCompany Announcements
Protalix outlines 2026 rare-disease growth and pipeline strategy
8M ago
8K
PLX
Protalix: Pipeline Expansion and Elfabrio Growth Drive Attractive Risk‑Reward and Undervalued Buy Rating
PremiumRatings
Protalix: Pipeline Expansion and Elfabrio Growth Drive Attractive Risk‑Reward and Undervalued Buy Rating
8M ago
PLX
Protalix, Secarna Pharmaceuticals enter collaboration and option agreement
PremiumThe Fly
Protalix, Secarna Pharmaceuticals enter collaboration and option agreement
8M ago
PLX
Protalix price target lowered to $12 from $15 at H.C. Wainwright
PremiumThe FlyProtalix price target lowered to $12 from $15 at H.C. Wainwright
9M ago
PLX
Protalix BioTherapeutics Reports Strong Revenue Growth in 2025
Premium
Company Announcements
Protalix BioTherapeutics Reports Strong Revenue Growth in 2025
9M ago
PLX
Protalix BioTherapeutics’ Earnings Call Highlights Growth and Challenges
Premium
Company Announcements
Protalix BioTherapeutics’ Earnings Call Highlights Growth and Challenges
9M ago
PLX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >